Byoung Chul Cho, M.D., Ph.D. (@cbcbc1971) header
Byoung Chul Cho, M.D., Ph.D. (@cbcbc1971) profile picture

Professor, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine

Seoul, Rep. of Korea
Joined August 2021
Photo by Byoung Chul Cho, M.D., Ph.D. (@cbcbc1971)Photo by Byoung Chul Cho, M.D., Ph.D. (@cbcbc1971)Photo by Byoung Chul Cho, M.D., Ph.D. (@cbcbc1971)
Byoung Chul Cho, M.D., Ph.D. retweeted
Today, we presented new preclinical #data supporting intracranial activity of NVL-655 at #AACR23. Thank you to our collaborators Dr. Cho @cbcbc1971 and his group at Yonsei University College of Medicine. bit.ly/3opryDI
5
1
14
1,344
Byoung Chul Cho, M.D., Ph.D. retweeted
Repotrectinib data presented by @cbcbc1971 . #ena2022 #ROS1
2
3
Byoung Chul Cho, M.D., Ph.D. retweeted
On National Lung Cancer Screening Day, I would like to thank and support the efforts of Byoung Chul Cho @cbcbc1971 & his study -Novel drug for #LungCancer showing promise in early-stage clinical trials @marjoriezettler Learn how @qure_ai is working for the cause. #RSNA22
9
27
Byoung Chul Cho, M.D., Ph.D. retweeted
Replying to @cbcbc1971
@cbcbc1971 nicely overviewed antibody-drug conjugates (ADCs), bispecific antibodies. T-DXd, Dato-DXd, HER3-DXd, Teliso-V, Amivantamab, and Tarlatamab, etc. #LCSM #TASLC
1
2
528
Byoung Chul Cho, M.D., Ph.D. retweeted
Looking forward to seeing you at #WCLC2021!! If anyone else is interested in Antibody–Drug Conjugates in #lungcancer, Please come to the education session ES04 at @WCLC2021 on Sep 10.
1
1